Interactions with Health Care Professionals
Our Position on the Physician Payments Sunshine Act
Bristol-Myers Squibb is committed to the highest standards of integrity and ethics. As an early proponent of transparency, we support the Physician Payments Sunshine Act as an extension of our own efforts to increase public awareness of the positive role that physician-industry collaboration plays in helping patients prevail over serious diseases.
Each medical advance that we deliver to patients is the result of many years of research and development. Throughout this process of scientific innovation, we collaborate with some of the country’s foremost medical experts and academic researchers, whose deep knowledge, expertise and insight helps ensure our medicines meet the needs of patients.
The Centers for Medicare and Medicaid Services’ (CMS) public database will provide patients and other stakeholders a new resource for understanding the positive ways in which U.S. physicians, researchers and CMS teaching hospitals collaborate with industry to advance the science of medicine.
We will fully comply with all Sunshine Act reporting requirements and will submit our initial disclosure report to CMS by March 31, 2014.
For questions or comments related to our position or company practices related to the Physician Payments Sunshine Act, please contact us at: email@example.com.